title: [Safety analysis of Allergovit immunotherapy in patients of allergic rhinitis].
abstract: OBJECTIVE
  To analyse the safety of Allergovit immunotherapy in patients of allergic rhinitis.
  
  
  METHODS
  Two hundred and fifty-six patients with allergic rhinitis received Allergovit immunotherapy, their local and systemic side-effect were observed, recorded and analyzed during the treatment.
  
  
  RESULTS
  The number of patients who got local side-effect was 84 cases, the percent of local side-effect was 4.45%; the number of patients who got systemic side-effect were 21 cases, the percent of systemic side-effect was 0.31%. Both side-effects were slight.
  
  
  CONCLUSIONS
  Allergovit immunotherapy is a safe and feasible choice for allergic rhinitis. While the schedule fit for Chinese or individually is needed to be mended in practice.
authors.affiliation: Department of Otorhinolaryngology, Union Hospital, Huazhong University of Science and Technology, Wuhan, 430022. jj-c@tom.com
authors.forename: Jianjun
authors.initials: J
authors.lastname: Chen
authors.forename: Jisheng
authors.initials: J
authors.lastname: Xiang
authors.forename: Weijia
authors.initials: W
authors.lastname: Kong
authors.forename: Hong
authors.initials: H
authors.lastname: Shu
authors.forename: Qiumei
authors.initials: Q
authors.lastname: Shi
authors.forename: Huifang
authors.initials: H
authors.lastname: Tan
mesh_terms: D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000628:therapy; D008297:Male; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*; D014612:Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D014612:Vaccines; C099681:allergovit